Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 1 non-open-market transaction below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

1 other filing hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
May 8, 2023 CBIO P 13,500 $1.57 $21,195 138,980 Direct +10.76% Acquired -90.9% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 12, 2024 CBIO Employee Stock Option (right to buy) Common Stock (250,000) $3.11 Jan. 11, 2034 250,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
March 31, 2023 CBIO Common Stock 125,480 Direct
March 31, 2023 CBIO Employee Stock Option (right to buy)→ Common Stock (235,000) 235,000 Direct
March 31, 2023 CBIO Employee Stock Option (right to buy)→ Common Stock (200,000) 200,000 Direct